Top Markets
#1 AI XOVIA AI XOVIA +120.61%
#2 Seeker Seeker +115.90%
#3 MowCat MowCat +108.37%
#4 Helium Helium +82.89%
#5 Pons Pons +52.72%
#6 UnifAI Network UnifAI Network +37.02%
#7 Zora Zora +34.86%
#8 Zylo Ecosystem Zylo Ecosystem +20.50%
#9 Bounce Bounce +19.62%
#10 ZKsync ZKsync +16.59%
Coin of the day
AI XOVIA AI XOVIA
Instellingen
Taal
DUTCH
Valuta
USD
Thema
Ergomed plc Ergomed plc

Ergomed plc

2EM
Rang in aandelen #11482
Ergomed plc, alongside its affiliated entities, offers a comprehensive range of... Ergomed plc, alongside its affiliated entities, offers a comprehensive range of clinical trial services, encompassing planning, oversight, and execution, in addition to providing essential drug safety and medical information support. The company maintains an expansive global footprint, conducting operations throughout the United Kingdom, continental Europe, the Middle East, Africa, North America, Asia, and Australia. Its business is organized into two core divisions: Clinical Research Services and Pharmacovigilance. Ergomed assists pharmaceutical, biotechnology, and generic drug manufacturers by managing clinical development programs, facilitating post-market approval strategies, and delivering robust pharmacovigilance solutions. Their expertise is concentrated in several therapeutic domains, including oncology, haematology, allergy, respiratory, and neurology/CNS, with a notable specialization in the development of orphan drugs. Furthermore, they extend support services to clinical trial sites. Established in 1997, the organization originally traded as Ergomed Clinical Research Limited before rebranding as Ergomed plc in June 2014. Its corporate headquarters are situated in Guildford, United Kingdom.
Aandeelprijs
$13.05
Laatst gesynchroniseerd: 2023-03-31
Marktkapitalisatie
$695.07M
Verandering (1 dag)
4.59%
Verandering (1 jaar)
0.00%
Land
GB
Handel Ergomed plc (2EM)

Categorie

Healthcare
P/S-ratio voor Ergomed plc (2EM)
P/S-ratio op 2026 TTM: 0
Volgens de meest recente financiële rapporten en aandelenkoers van Ergomed plc is de huidige P/S-ratio (TTM) 0. Eind 2026 had het bedrijf een P/S-ratio van 0.
P/S-ratiohistoriek voor Ergomed plc van 2026 tot 2026
P/S-ratio aan het einde van elk jaar
Jaar P/S-ratio Wijzigen
Niet genoeg gegevens voor de verstrekte datums.
P/S-ratio voor vergelijkbare bedrijven of concurrenten
Bedrijf P/S-ratio Verschil in P/S-ratio Land
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH